A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
1 other identifier
observational
2,929
1 country
10
Brief Summary
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedMay 21, 2018
May 1, 2018
Same day
February 2, 2018
May 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival
Overall survival
2014 - 2017
Secondary Outcomes (1)
Disease-free survival
2014 - 2017
Other Outcomes (16)
Overall survivals in the subgroups
2014 - 2017
Disease-free survivals in the subgroups
2014 - 2017
Impact factors of overall survival as measured by age
2014 - 2017
- +13 more other outcomes
Study Arms (2)
Surgeries+adjuvant chemotherapies
Patients who received radical resection of lung cancer + adjuvant chemotherapies
Perioperative chemotherapies
Patients who received perioperative chemotherapies
Interventions
Surgeries plus adjuvant chemotherapies or perioperative chemotherapies
Eligibility Criteria
Pathologically diagnosed Chinese patients with N2 non-small cell lung cancer who received radical resection of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies
You may qualify if:
- Patients with radical resection of lung cancer enrolled from 2014 to 2019;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Patients with age \> 18 years old;
- Patients who did not receive chest surgeries before hospitalization;
- Patients with N2 lymph nodes (+) after surgeries;
- Patients who received lymphadenectomy for one group or more groups of lymph nodes;
You may not qualify if:
- Patients with second primary tumors or multiple primary tumors;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
- LinkDoc Technology (Beijing) Co. Ltd.collaborator
Study Sites (10)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
China PLA General Hospital
Beijing, Beijing Municipality, 100853, China
Henan cancer hospital
Zhengzhou, Henan, 450008, China
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, 430030, China
Jiangsu cancer hospital
Nanjing, Jiangsu, 210009, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, 710000, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200003, China
Huaxi Hospital Affiliated to Sichuan University
Chengdu, Sichuan, 610041, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, 300051, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, 310003, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 2, 2018
First Posted
March 1, 2018
Study Start
December 1, 2017
Primary Completion
December 1, 2017
Study Completion
March 30, 2018
Last Updated
May 21, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share